-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Teva Pharmaceutical Indus, Maintains $54 Price Target

Benzinga·11/17/2026 12:10:15
Listen to the news
HC Wainwright & Co. analyst Douglas Tsao reiterates Teva Pharmaceutical Indus (NYSE:TEVA) with a Buy and maintains $54 price target.